Bookmark and Share
BioAssay: AID 623883

SAR Analysis for the identification of inhibitors of the two-pore domain potassium channel KCNK9 - Selectivity assay against hERG: FluxOR Assay CRC 4

Name: SAR Analysis for the identification of inhibitors of the two-pore domain potassium channel KCNK9 - Selectivity assay against hERG: FluxOR Assay CRC 4 ..more
_
   
 Tested Compounds
 Tested Compounds
All(25)
 
 
Active(10)
 
 
Inactive(16)
 
 
 Tested Substances
 Tested Substances
All(28)
 
 
Active(10)
 
 
Inactive(18)
 
 
AID: 623883
Data Source: Johns Hopkins Ion Channel Center (K9_Inh_SAR_hERG_CRC_4)
BioAssay Type: Confirmatory, Concentration-Response Relationship Observed
Depositor Category: NIH Molecular Libraries Probe Production Network
Deposit Date: 2012-03-27
Hold-until Date: 2013-03-26
Modify Date: 2013-03-26

Data Table ( Complete ):           View Active Data    View All Data
Target
BioActive Compounds: 10
Related Experiments
Show more
AIDNameTypeComment
488922Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9Screeningdepositor-specified cross reference: Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium
488964Summary of probe development for inhibitors of the two-pore domain potassium channel KCNK9Summarydepositor-specified cross reference: Summary of probe development for inhibitors of the two-pore domain potassium channel KCNK9
492992Confirmatory screen for identification of compounds that inhibit the two-pore domain potassium channel (KCNK9)Screeningdepositor-specified cross reference: Confirmatory screen for identification of compounds that inhibit the two-pore domain potassium chann
504920SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in hERG expressing cells: FluxOR Assay CRC for hERG SpecificityConfirmatorydepositor-specified cross reference
540323SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in hERG expressing cells: FluxOR Assay CRC 2Confirmatorydepositor-specified cross reference
492993Specificity screen against Kir2.1 for compounds that modulate the two-pore domain potassium channel (KCNK9)Screeningsame project related to Summary assay
492997Second counter screen for compounds that modulate the two-pore domain potassium channel (KCNK9)Screeningsame project related to Summary assay
504846SAR analysis for compounds that inhibit the two-pore domain potassium channel KCNK9Confirmatorysame project related to Summary assay
504902SAR Analysis for the identification of selective inhibitors of KCNK9 against parental cells: FluxOR Assay CRCConfirmatorysame project related to Summary assay
504922SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in Kir2.1 expressing cells: FluxOR Assay CRCConfirmatorysame project related to Summary assay
540321SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in Kir2.1 expressing cells: FluxOR Assay CRC 2Confirmatorysame project related to Summary assay
540322SAR analysis for compounds that inhibit the two-pore domain potassium channel KCNK9 IIConfirmatorysame project related to Summary assay
540324SAR Analysis for the identification of selective inhibitors of KCNK9 against parental cells: FluxOR Assay CRC 2Confirmatorysame project related to Summary assay
588724SAR analysis for compounds that inhibit the two-pore domain potassium channel KCNK9 IIIConfirmatorysame project related to Summary assay
588741SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in hERG expressing cells: FluxOR Assay CRC 3Confirmatorysame project related to Summary assay
588759SAR Analysis for the identification of selective inhibitors of KCNK9 against parental cells: FluxOR Assay CRC 3Confirmatorysame project related to Summary assay
588760SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in Kir2.1 expressing cells: FluxOR Assay CRC 3Confirmatorysame project related to Summary assay
588761SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in KCNQ2 expressing cells: FluxOR Assay CRCConfirmatorysame project related to Summary assay
588776SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in KCNK3 expressing cells: FluxOR Assay CRC 1Confirmatorysame project related to Summary assay
588798SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in KCNQ2 expressing cells: FluxOR Assay CRC 3Confirmatorysame project related to Summary assay
588800SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in KCNQ2 expressing cells: FluxOR Assay CRC 2Confirmatorysame project related to Summary assay
623881SAR Analysis for the identification of selective inhibitors of the two-pore domain potassium channel KCNK9 in Kir2.1 expressing cells: FluxOR Assay CRC 4Confirmatorysame project related to Summary assay
623884SAR Analysis for the identification of selective inhibitors of KCNK9 against parental cells: FluxOR Assay CRC 4Confirmatorysame project related to Summary assay
623886SAR Analysis for the identification of inhibitors of the two-pore domain potassium channel KCNK9 - Selectivity assay against KCNQ2: FluxOR Assay CRCConfirmatorysame project related to Summary assay
623887SAR analysis for compounds that inhibit the two-pore domain potassium channel KCNK9 4Confirmatorysame project related to Summary assay
623894SAR Analysis for the identification of inhibitors of the two-pore domain potassium channel KCNK9 - Selectivity assay against KCNK3: FluxOR Assay CRC 3Confirmatorysame project related to Summary assay
623898SAR analysis for the identification of selective inhibitors of the two-pore domain potassium channel (KCNK9): Automated ElectrophysiologyConfirmatorysame project related to Summary assay
623912SAR Analysis for the identification of inhibitors of the two-pore domain potassium channel KCNK9 - Selectivity assay against KCNK3: FluxOR Assay CRC 2Confirmatorysame project related to Summary assay
623913SAR Analysis for the identification of inhibitors of the two-pore domain potassium channel KCNK9 - Selectivity assay against KCNQ2: FluxOR Assay CRC 4Confirmatorysame project related to Summary assay
623914SAR Analysis for the identification of inhibitors of the two-pore domain potassium channel KCNK9 - Selectivity assay against KCNQ2: FluxOR Assay CRC 2Confirmatorysame project related to Summary assay
623915SAR analysis for the identification of selective inhibitors of the two-pore domain potassium channel (KCNK9) -selectivity assay against KCNK3: Automated ElectrophysiologyConfirmatorysame project related to Summary assay
624121SAR analysis for the identification of selective inhibitors of the two-pore domain potassium channel (KCNK9): Manual ElectrophysiologyOthersame project related to Summary assay
Description:
Data Source: Johns Hopkins Ion Channel Center
BioAssay Type: Confirmatory, Concentration-Response Relationship Observed

Source (MLPCN Center Name): Johns Hopkins Ion Channel Center (JHICC)
Center Affiliation: Johns Hopkins University, School of Medicine
Screening Center PI: Min Li, Ph.D.
Assay Provider: Meng Wu, Ph.D., Johns Hopkins University, School of Medicine
Network: Molecular Libraries Probe Production Centers Network (MLPCN)
Grant Proposal Number: R03 MH090849-01
Grant Proposal PI: Meng Wu, Ph.D., Johns Hopkins University, School of Medicine
Assay Implementation: Melissa Miller, Shunyou Long M.S., David Meyers Ph.D., Owen Mcmanus Ph.D.

Name: SAR Analysis for the identification of inhibitors of the two-pore domain potassium channel KCNK9 - Selectivity assay against hERG: FluxOR Assay CRC 4

Description:

The purpose of this assay is to assess the specificity of compounds identified as inhibitors of KCNK9. This specificity screen is to eliminate any compounds that interact with the voltage-gated potassium channel, hERG. Compound inhibition of hERG was tested in at least duplicate using a thallium sensitive dye.
Protocol
Protocol:
1. Cell culture: Cells are routinely cultured in DMEM/F12 medium, supplemented with 10% Fetal Bovine Serum (FBS), 50 IU/ml penicillin, 50ug/ml streptomycin,and 500ug/ml G418.
2. Cell plating: Add 50 ul/well of 120,000 cells/ml re-suspended in DMEM/F12 medium with 10% FBS
3. Incubate overnight at 37C and 5% CO2
4. Remove medium and add 25 ul/well of 1x FluxOR solution to cells
5. Incubate 90 minutes at room temperature (RT) in the dark
6. Prepare 7.5x compound plates and control plates on Cybi-Well system: test compounds are prepared using assay buffer containing IC70 of dofetilide; controls are assay buffer, IC70, and ICmax of dofetilide (all with DMSO concentrations matched to that of test compounds)
7. Remove FluxOR dye solution and add 20 ul/well of assay buffer to cells
8. Add 4 ul of 7.5x compound stock into the cell plates via Cybi-Well system
9. Incubate all cell plates for 20 minutes at RT in the dark
10. Prepare 5x stimulus buffer containing 25 mM K2SO4 and 7 mM Tl2SO4
11. Load cell plates to Hamamatsu FDSS 6000 kinetic imaging plate reader
12. Measure fluorescence for 10 seconds at 1Hz to establish baseline
13. Add 6 ul/well of stimulus buffer onto cells and continue measuring fluorescence for 110 seconds
14. Calculate ratio readout as F(max-min)/F0
15. Calculate the average and standard deviation for negative and positive controls in each plate, as well as Z and Z' factors
16. IC50 and Hill Constant calculation from replicates was generated using Microcol Origin 6.0
17. Outcome assignment: If the test compound causes a maximum inhibition of hERG greater than 30% in any concentration tested and a dose response curve is generated, the compound is considered to be active (outcome=2). If the test compound does not cause inhibition of hERG at any concentration tested or a dose response is not generated, the compound is designated as inactive (outcome=1).
16. Score assignment: Compounds with an IC50 less than 1uM are given a score of 100, 1uM-5uM a score of 75, 5uM-10uM a score of 50, 10uM-20uM a score of 25 and any compound with an IC50 greater than 20uM or those that are designated inactive in the outcome are given a score of 0.
List of reagents
1. hERG CHO cell lines (provided by JHICC)
2. PBS: pH7.4 (Gibco, Cat #10010)
3. Medium: DMEM/F12 50/50 (Mediatech, Cat #15-090-CV)
4. Fetal Bovine Serum (Gemini, Cat #100106)
5. 200 mM L-Glutamine (Gibco, Cat #25030)
6. 100x Penicillin-Streptomycin (Mediatech, Cat #30-001-CI)
7. 0.25% Trypsin-EDTA (Gibco, Cat #25300)
8. Geneticin: (Gibco, Cat #11811-031)
9. HEPES (Sigma, Cat #H4034)
10. Dofetilide (Fisher, Cat #NC9753685)
11. FluxOR detection kit (Invitrogen, Cat #F10017): FluxOR, assay buffer and stimulus buffer.
12. Triple-layer flask (VWR, Cat #62407-082)
13. BD Biocoat 384-well plates (BD, Cat #354663 and Lot #7346273)
Comment
Possible artifacts of this assay can include, but are not limited to: non-intended chemicals, or dust in or on wells of the microtiter plate, compounds that non-specifically modulate the cell host or the targeted activity, and compounds that quench or emit light or fluorescence within the well. All test compound concentrations reported are nominal; the specific concentration for a particular test compound may vary based upon the actual sample provided by the MLSMR. The conditions of this assay are optimal for screening for compounds that modulate KCNK9 channels, NOT for the assay of hERG modulators. Normalization is to this set of data and cannot be used for comparison with other counter screens.
Result Definitions
Show more
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1IC50*IC50 (uM)FloatμM
2Ratio at 30uM (30μM**)Ratio for KCNK9 at the specified compound concentrationFloat
3SD at 30uMStandard Deviation of measurement of KCNK9 ratio at the specified concentrationFloat
4Ratio at 10uM (10μM**)Ratio for KCNK9 at the specified compound concentrationFloat
5SD at 10uMStandard Deviation of measurement of KCNK9 ratio at the specified concentrationFloat
6Ratio at 3.33uM (3.33μM**)Ratio for KCNK9 at the specified compound concentrationFloat
7SD at 3.33uMStandard Deviation of measurement of KCNK9 ratio at the specified concentrationFloat
8Ratio at 1.11uM (1.11μM**)Ratio for KCNK9 at the specified compound concentrationFloat
9SD at 1.11uMStandard Deviation of measurement of KCNK9 ratio at the specified concentrationFloat
10Ratio at 370nM (0.37μM**)Ratio for KCNK9 at the specified compound concentrationFloat
11SD at 370nMStandard Deviation of measurement of KCNK9 ratio at the specified concentrationFloat
12Ratio at 123nM (0.123μM**)Ratio for KCNK9 at the specified compound concentrationFloat
13SD at 123nMStandard Deviation of measurement of KCNK9 ratio at the specified concentrationFloat
14Ratio at 41.1nM (0.041μM**)Ratio for KCNK9 at the specified compound concentrationFloat
15SD at 41.1nMStandard Deviation of measurement of KCNK9 ratio at the specified concentrationFloat
16Ratio at 13.7nM (0.013μM**)Ratio for KCNK9 at the specified compound concentrationFloat
17SD at 13.7nMStandard Deviation of measurement of KCNK9 ratio at the specified concentrationFloat
18Ratio at 4.57nM (0.00457μM**)Ratio for KCNK9 at the specified compound concentrationFloat
19SD at 4.57nMStandard Deviation of measurement of KCNK9 ratio at the specified concentrationFloat
20Ratio at 1.52nM (0.00152μM**)Ratio for KCNK9 at the specified compound concentrationFloat
21SD at 1.52nMStandard Deviation of measurement of KCNK9 ratio at the specified concentrationFloat
22NNumber of replicates for KCNK9 ratio measurementsInteger
23Hill ConstantHill constant of fittingFloat

* Activity Concentration. ** Test Concentration.
Additional Information
Grant Number: 1 R03 MH090849-01

Data Table (Concise)
Data Table ( Complete ):     View Active Data    View All Data
PageFrom: